 |
 |
 |
||||||||||||||
|
 |
 |
 |
|
 |
|
 |
|
 |
|
 |
|
||||
| < 2004 News Listings | ||||||||||||||||
|
BEVERLY, MA December 9, 2004 Dr. Csaba Szabă has received the 2004 Dennis Gabor Award in Budapest, Hungary. This award, named after Nobel Laureate Hungarian Physicist Dennis Gabor, the inventor of the holography, is given annually to a handful of scientists of Hungarian origin for discovery and innovation achievements. The awardees' expertise range between physics, chemistry, economics and engineering and, in rare instances, biology and medicine. According to the awarding committee, Dr. Szabo was given the award for his groundbreaking research into the pathomechanisms of cardiovascular and inflammatory diseases and for his contributions to the development of novel therapeutics related to these mechanisms. Previous Dennis Gabor awardees include Erno Rubik, the inventor of Rubik's cube. About Inotek Pharmaceuticals Inotek Pharmaceuticals Corporation is a private, high-growth, development-stage pharmaceutical company. Inotek has one product in Phase II human clinical development, one product in Phase I human clinical trials and five other products that will enter human clinical trials in the next 6-12 months. Since the firm was founded in 1996, Inotek researchers have been focused on discovering and optimizing small-molecule therapeutics that target mechanisms of cell necrosis, tissue injury and inflammatory disease. The Company's teams of molecular biologists, chemists & pharmacologists have discovered thousands of potent, small-molecule compounds which act on various critical targets associated with cell death, inflammation and vascular dysfunction including nitric oxide, super oxide, peroxynitrite, poly (ADP-ribose) polymerase (PARP), adenosine receptors (A1, A2a and A3), xanthine oxidase and others. Contact: Jeffrey T. Walsh Vice President, Corporate Development and Commercial Planning Inotek Pharmaceuticals Corporation (978) 232-9660 x388 |
|
|
Copyright ©2007 Rho Capital Partners, Inc.